MIRA INFORM REPORT

 

 

Report No. :

306915

Report Date :

09.02.2015

 

IDENTIFICATION DETAILS

 

Name :

THE IBN SINA PHARMACEUTICAL INDUSTRY LTD.

 

 

Registered Office :

House # 41, Road # 10/A, Dhanmondi, Dhaka-1209

 

 

Country :

Bangladesh

 

 

Financials (as on) :

30.09.2014

 

 

Date of Incorporation :

22.12.1983

 

 

Com. Reg. No.:

C-11424

 

 

Legal Form :

Public Listed Co      

 

 

Line of Business :

Manufacturer, Exporter, Importer and Marketing of Tablets, Capsules & Other Medicine

 

 

No of Employees :

3000

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

Bangladesh

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

B2

Moderate High Risk

 

C1

High Risk

C2

Very High Risk

D

 

 

BANGLADESH ECONOMIC OVERVIEW

 

Bangladesh's economy has grown roughly 6% per year since 1996 despite political instability, poor infrastructure, corruption, insufficient power supplies, slow implementation of economic reforms, and the 2008-09 global financial crisis and recession. Although more than half of GDP is generated through the service sector, almost half of Bangladeshis are employed in the agriculture sector with rice as the single-most-important product. Garment exports, the backbone of Bangladesh’s industrial sector and 80% of total exports, surpassed $21 billion last year, 18% of GDP. The sector has remained resilient in recent years amidst a series of factory accidents that have killed over 1,000 workers and crippling strikes that shut down virtually all economic activity. Steady garment export growth combined with remittances from overseas Bangladeshis, which totaled almost $15 billion and 13% of GDP IN 2013, are the largest contributors to Bangladesh’s current account surplus and record foreign exchange holdings.

 

Source : CIA

 

 

IDENTIFICATION DETAILS

 

 

 

Correct company Name

:

The Ibn Sina Pharmaceutical Industry Ltd.

 

Head Office

:

House # 41, Road # 10/A, Dhanmondi, Dhaka-1209, Bangladesh.

 

Tel No

:

88-02-9114710, 9117496, 9138617, 9132521

 

Fax No

:

Nil

 

E-mail

:

info@ibnsinapharma.com, ibnsina@bangla.net

 

Website

:

www.ibnsinapharma.com

 

Date/ Year of Incorporation

:

22.12.1983

 

Incorporation No.

:

C-11424

 

Legal Form (General)

:

 Public Listed Co        Public (but not listed)   Private Co   State-owned Co

 Sole Proprietorships  Partnership                     Not Registered

 others (please specify) ________________

 

Legal form (Specific)

:

LTD   CORP    INC  CO    

 others (please specify) ________________

 

Issuing Authority

:

Registrar of Joint Stock Companies & Firms      City Corporation

 Municipal Administration                                   Union Council

 Cantonment Board                                              Chief Controller of  Import & Export (CCIE)

 

 

 

FINANCIALS- SUMMARY

 

      Year

Turnover/ Sales

 Assets

     Income/(Loss)

31.12.2013

BDT 1,569,928,882

                        (01.01.2013~30.09.2013)

BDT 1,096,432,108

BDT 45,394,911

           (01.01.2013~30.09.2013)

30.09.2014

BDT 1,970,236,676

                       (01.01.2013~30.09.2014)

BDT 1,078,513,463

BDT60,567,831

          (01.01.2013~30.09.2014)

Exchange Rate

USD1-Tk. 77.8200

EUR 1- Tk. 100.2711

GBP 1- Tk.118.5354

AUD 1 - Tk.82.8563

JPY 1 - Tk.0.9286

CAD 1 - Tk.80.1887

SEK 1 - Tk.12.2870

SGD 1 - Tk.65.3045

CNH 1 - Tk.12.8399

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FULLCHECK REPORT DETAILS

 

                                                             Information Parted By

 

 

 

Name

:

Mr. Md. Shahid Farooqui

Designation

:

Company Secretary

Contract No

:

-

 

 

                                                               Locations Details

 

Operating Address

:

House # 41, Road # 10/A, Dhanmondi, Dhaka-1209, Bangladesh.

Tel No

:

88-02-9114710, 9117496, 9138617, 9132521

Fax No

:

Nil

E-mail

:

info@ibnsinapharma.com, ibnsina@bangla.net

Website

:

www.ibnsinapharma.com

 

Location :

: Owned

Ö

 

Rented

 

 

Leased

 

Area

4500

Sq. ft.

 

 

Type of Office :

  :       Commercial Office Bldg.

Ö

 

Semi-commercial office Bldg.

 

     

 

Retail shop

 

 

Industrial Park

 

     

 

Business Center

 

 

Home Office

 

     

 

Residential Bldg.

 

 

 

 

 

 

 

Factory:

 

 

 

 

 

Address

:

Shafipur, Gazipur Bangladesh.                                                                                     

Tel No

:

88-068-2251403, 2251404

Fax No

:

Nil

 

Location :

   Owned

Ö

 

Rented

 

 

Leased

 

Area

15

Acores

 

 

Branches:

 

 

 

 

 

Address

:

Nil

Tel No

:

Nil

Fax No

:

Nil

 

Employee:

 

 

 

No. of Employees 

 

In Office

:

350

In Factory

:

2650

In Branch:

:

-

Total

:

3000

Details:

 

                    

 

 

 

OWNERSHIP/SHAREHOLDERS

 

         Names of Shareholders

                      No. of Share     

Mr. Advocate Mujibur Rahman

67284

Mr. Prof. A.N.M.A. Zaher

67476

Mr. Commodore (Retd.) M.A. Rahman

69336

Mr. Mir Quashem Ali

70716

Mr. Shah Abdul Hannan

69696

Mr. Prof. Dr. A.K.M. Sadrul Islam

63756

Mr. Prof. Dr. Matiur Rahman

 1500

Mr. Prof. Dr. Shah Md. Bulbul Islam

   360

Mr. Dr. Shamsuddin Ahmed

65076

General Public

                               20973876

 

 

DIRECTORS

 

Name

Designation

Mr. Shah Abdul Hannan

Chairman

Mr. Prof. A.N.M.A. Zaher

Managing Director

Mr. Commodore (Retd.) M.A. Rahman

Director

Mr. Prof. Dr. A.K.M. Sadrul Islam

Finance Director

Mr. Prof. Dr. Chowdhury Mahmud Hasan

Director

Mr. Prof. Dr. Matiur Rahman

Director

Mr. Prof. Dr. Shah Md. Bulbul Islam

Director

Mr. Md. Abdus Salam

Independent Director

J Mr. b. Abdur Raquib

Independent Director

 

 

Management

 

Name

:

Mr. Md. Shahid Farooqui

Job Description

:

Company Secretary

Nationality

:

Bangladeshi

Email address

:

N/A

Other details

:

N/A

 

 

 

Name

:

Prof. Dr. A. K. M. Sadrul lslam

Job Description

:

Finance Director

Nationality

:

Bangladeshi

Email address

:

N/A

Other details

:

N/A

 

 

BUSINESS OPERATIONS

 

Nature of Activity       :

Manufacturer

Ö

Trader

 

Marketing

Ö

Distributor

 

 

 

 

Exporter

Ö

Importer

Ö

Services

 

Others

 

 

 

Item Dealings In:

 

Products

:

Tablets, Capsules & Other Medicine

Production Capacity

:

N/A

Last Year Production

:

N/A

 

 

Trading Terms:

 

Purchasing Terms:

L/C

Ö

Cash

 

Others

 

 

 

Credit :

 

30 days

 

60 days

Ö

90 days

 

 

days

 

Selling Terms      :

L/C

Ö

Cash

 

Others

 

 

 

Credit :

 

30 days

 

60 days

Ö

90 days

 

 

days

 

 

DETAILED DATA

 

 

Trade Reference & Related Parties

:

 

Overseas Clients

:

N/A

Local Clients

:

N/A

 

Overseas Suppliers

:

N/A

Local Suppliers

:

N/A

 

Trade Markets

 

:

 

Exports

:

Vietnam, Yemen, Cambodia, Myanmar, Sri Lanka.

 

Imports

:

China, India, Pakistan, Japan, Indonesia.

 

 

 

Brand Name

:

N/A

Certified

:

ISO 9001:2000

Auditors

:

Huda Hossain & Co.

Chartered Accountants

230, New Elephant Road, (4th Floor)

Dhaka-1205, Bangladesh

Operation Status

:

Active

Member

:

N/A

 

 

CAPITAL STRUCTURE

 

 

Authorized Capital

:

BDT 500 Million

 

Paid-up Capital

:

BDT 213,840,000

    No. of Shares

:

2,13,84,000

Share Value

:

BDT 10.0Each

Main Assets

:

BDT 1,078,513,463

 

 


 

FINANCIAL STATEMENT- DETAILED

 

Balance Sheet :

 

  Currency

: Tk.

 

       Denomination

: 1

 

         Financial Year Ending

: 30thS eplembe2r0, 14

 


 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income Statement :

 

  Currency

: Tk.

 

       Denomination

: 1

 

         Financial Year Ending

: 30thS eplembe2r0, 14

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ASSOCIARES/SUBSIDIARIES/ RELATED PARTIES

 

Sister Concerns

:

IBN Sina Hospital (100 beds)

IBN Sina Diagnostic Lab

IBN Sina Imaging Centre

IBN Sina Consolation Centre

IBN Sina Medical Check-Up

IBN Sina Medical College

IBN Sina Pharmaceuticals Industry

Subsidiary

:

Nil

Name of  The Group

:

IBN Sina Trust

 

 

BANKING

 

 

Bank Name  

:

Islami Bank Bangladesh Ltd.

Al-Arafah Islami Bank Ltd.

Prime Bank Ltd

First Security Islami Bank Ltd

 

 

ADVERSE DATA MONITORING

 

Dishonored Checks           

 

:     

No Record Found         

Debt

 

:

No Record Found

Litigation  

                   

:

Clear         

Performance Defaults

 

:

No Record Found         

Adverse Local Media Coverage/ Adverse Filling History

:

No Record Found

 

 

SITE VISIT COMMENTARY

Our Representative Visited the subject company Head office which is situated at House # 41, Road # 10/A, Dhanmondi, Dhaka-1209, Bangladesh. It is situated at residential area.

 

 

GENERAL COMMENTS

The subject company is a well-known reputed company in Bangladesh.  Their products popular to the local customers.   So day by day the subject companies increase their goodwill.

As well as its financial condition, we recommend that Credit can precede promptly Fairly large amount.

 

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 61.73

UK Pound

1

Rs. 94.65

Euro

1

Rs. 70.78

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

DPT

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.